These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8752177

  • 1. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.
    Pass HI, Mew DJ, Carbone M, Matthews WA, Donington JS, Baserga R, Walker CL, Resnicoff M, Steinberg SM.
    Cancer Res; 1996 Sep 01; 56(17):4044-8. PubMed ID: 8752177
    [Abstract] [Full Text] [Related]

  • 2. The effect of an antisense expression plasmid to the IGF-1 receptor on hamster mesothelioma proliferation.
    Pass HI, Mew DJ, Carbone M, Donington JS, Baserga R, Steinberg SM.
    Dev Biol Stand; 1998 Sep 01; 94():321-8. PubMed ID: 9776253
    [Abstract] [Full Text] [Related]

  • 3. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor.
    Long L, Rubin R, Baserga R, Brodt P.
    Cancer Res; 1995 Mar 01; 55(5):1006-9. PubMed ID: 7866982
    [Abstract] [Full Text] [Related]

  • 4. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
    Shain SA, Sarić T, Ke LD, Nannen D, Yoas S.
    Cell Growth Differ; 1996 May 01; 7(5):573-86. PubMed ID: 8732667
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
    Nakashiro K, Kawamata H, Hino S, Uchida D, Miwa Y, Hamano H, Omotehara F, Yoshida H, Sato M.
    Cancer Res; 1998 Feb 01; 58(3):549-55. PubMed ID: 9458104
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA, Delgado CH, Bartels CJ, Woodworth CD, Zou Z.
    Cancer Res; 1996 Apr 15; 56(8):1761-5. PubMed ID: 8620490
    [Abstract] [Full Text] [Related]

  • 7. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor.
    Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R.
    Cancer Res; 1994 Sep 15; 54(18):4848-50. PubMed ID: 8069850
    [Abstract] [Full Text] [Related]

  • 8. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor.
    Ambrose D, Resnicoff M, Coppola D, Sell C, Miura M, Jameson S, Baserga R, Rubin R.
    J Cell Physiol; 1994 Apr 15; 159(1):92-100. PubMed ID: 8138595
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
    Liu Y, Wang H, Zhao J, Ma J, Wei L, Wu S, Xie T, Shen F, Trojan J, Habib N, Anthony DD, Wu M, Guo Y.
    Cancer Gene Ther; 2000 Mar 15; 7(3):456-65. PubMed ID: 10766352
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.
    Szpechcinski A, Trzos R, Jarocki P, Trojan LA, Oficjalska K, Junkiert A, Wei MX, Mazurek M, Czapiewska JL, Niklinski J, Kopiński P, Chyczewski L, Kasacka I, Trojan J.
    Rocz Akad Med Bialymst; 2004 Mar 15; 49 Suppl 1():98-104. PubMed ID: 15638388
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV.
    Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317
    [Abstract] [Full Text] [Related]

  • 15. Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression.
    Lafarge-Frayssinet C, Duc HT, Frayssinet C, Sarasin A, Anthony D, Guo Y, Trojan J.
    Cancer Gene Ther; 1997 Jul 01; 4(5):276-85. PubMed ID: 9345599
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O, Bol DK, You J, Beltrán L, Rupp T, DiGiovanni J.
    Mol Carcinog; 1996 Oct 01; 17(2):62-9. PubMed ID: 8890954
    [Abstract] [Full Text] [Related]

  • 18. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.
    Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R.
    Cancer Res; 1994 Apr 15; 54(8):2218-22. PubMed ID: 8174129
    [Abstract] [Full Text] [Related]

  • 19. Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors.
    Pietrzkowski Z, Lammers R, Carpenter G, Soderquist AM, Limardo M, Phillips PD, Ullrich A, Baserga R.
    Cell Growth Differ; 1992 Apr 15; 3(4):199-205. PubMed ID: 1325181
    [Abstract] [Full Text] [Related]

  • 20. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
    Chambéry D, Mohseni-Zadeh S, de Gallé B, Babajko S.
    Cancer Res; 1999 Jun 15; 59(12):2898-902. PubMed ID: 10383152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.